Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
98,623,216
-
Share change
-
+326,233
-
Total reported value
-
$285,073,104
-
Put/Call ratio
-
3.6%
-
Price per share
-
$2.89
-
Number of holders
-
116
-
Value change
-
+$2,379,812
-
Number of buys
-
55
-
Number of sells
-
41
Institutional Holders of BIOSCRIP INC - COM (BIOS) as of Q3 2016
As of 30 Sep 2016,
BIOSCRIP INC - COM (BIOS) was held by
116 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
98,623,216 shares.
The largest 10 holders included
GABELLI FUNDS LLC, CAMBER CAPITAL MANAGEMENT LLC, NORTH TIDE CAPITAL, LLC, Coliseum Capital Management, LLC, DIAMOND HILL CAPITAL MANAGEMENT INC, ARDSLEY ADVISORY PARTNERS, VANGUARD GROUP INC, WYNNEFIELD CAPITAL INC, BlackRock Fund Advisors, and ROYAL BANK OF CANADA.
This page lists
116
institutional shareholders reporting positions in this security
for the Q3 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.